TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19816413

Group type: EXPERIMENTAL
Intervention: Aerobic training adherers
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Resistance training adherers
Number of subjects: 97

Group type: COMPARATOR
Intervention: Nonexercise group
Number of subjects: 97

Group type: COMPARATOR
Intervention: Aerobic nonadherers
Number of subjects: 97

Group type: COMPARATOR
Intervention: Resistance nonadherers
Number of subjects: 97
Study: 18720710

Group type: EXPERIMENTAL
Intervention: Trimetazidin (TMZ) 35 mg
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 135
Study: 15802415

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg-10 mg-5 mg-5 mg intravenously every 12 hours)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo (saline control)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 157
Study: 14674838

Group type: EXPERIMENTAL
Intervention: Medically treated hypertension
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normotensive peers
Number of subjects: 40
Study: 11787475

Group type: EXPERIMENTAL
Intervention: Moxonidine (0.4 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9061418

Group type: EXPERIMENTAL
Intervention: ioversol
Number of subjects: 59

Group type: COMPARATOR
Intervention: iohexol
Number of subjects: 59
Study: 1989736

Group type: EXPERIMENTAL
Intervention: Epidural butorphanol 1 mg
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Epidural butorphanol 2 mg
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Epidural butorphanol 4 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Morphine 5 mg
Number of subjects: 92
Study: 6410739

Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 20

Group type: COMPARATOR
Intervention: Amipaque (metrizamide)
Number of subjects: 20
Study: 30849943

Group type: EXPERIMENTAL
Intervention: Mass media promotion of a smartphone smoking cessation app
Number of subjects: 4400000
Study: 28629164

Group type: EXPERIMENTAL
Intervention: Femtosecond laser‐assisted cataract surgery (FLACS) using the FEMTO LDV Z8
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 130
Study: 27194530

Group type: EXPERIMENTAL
Intervention: Tofacitinib 0.5-15mg
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 24733807

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam with tigecycline (4.5 g IV every 8 hours + 50 mg IV every 12 hours; loading dose 100 mg)
Number of subjects: 390

Group type: COMPARATOR
Intervention: Piperacillin/tazobactam monotherapy
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam with tigecycline
Number of subjects: 390
Study: 22036036

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 3000 mg in divided doses
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ketamine (0.23 mg/kg bolus, followed by 0.58 mg/kg for 30 min, then 0.29 mg/kg for 40 min)
Number of subjects: 16
Study: 19769634

Group type: EXPERIMENTAL
Intervention: Oral Sodium Phosphosoda (OSPS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol (PEG)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combination of PEG and OSPS (PEG+OSPS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: PEG, OSPS, PEG+OSPS (all groups)
Number of subjects: 36
Study: 17291843

Group type: EXPERIMENTAL
Intervention: HRT plus exercise (n=37)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: NHRT plus exercise (n=35)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: HRT no exercise (n=35)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control (non-HRT no exercise, n=34)
Number of subjects: 141
Study: 16321186

Group type: EXPERIMENTAL
Intervention: Alfacalcidol 1.0 microg/d plus calcium carbonate 750 mg Tid
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Alfacalcidol 0.5 microg/d plus calcium carbonate 750 mg Tid
Number of subjects: 89

Group type: COMPARATOR
Intervention: Calcium carbonate 750 mg Tid
Number of subjects: 89
Study: 11895272

Group type: EXPERIMENTAL
Intervention: Healthy School and Drugs project (intervention)
Number of subjects: 1930
Study: 9866220

Group type: EXPERIMENTAL
Intervention: Electrodissection tonsillectomy
Number of subjects: 838

Group type: COMPARATOR
Intervention: Blunt dissection tonsillectomy
Number of subjects: 838
Study: 7615230

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg orally once daily for 7 days (n=8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (n=8)
Number of subjects: 16
Study: 2613380

Group type: EXPERIMENTAL
Intervention: Metoprolol (50-100 mg twice a day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Verapamil (40-80 mg three times a day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Digoxin (0.25-0.5 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 20
Study: 1268490

Group type: EXPERIMENTAL
Intervention: Home care by family doctor
Number of subjects: 450

Group type: COMPARATOR
Intervention: Hospital care (initially in an intensive care unit)
Number of subjects: 450
Study: 31260872

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 28077460

Group type: EXPERIMENTAL
Intervention: Glyburide
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Combination of glyburide and metformin
Number of subjects: 104

Group type: COMPARATOR
Intervention: Glyburide and Metformin
Number of subjects: 104
Study: 25541376

Group type: EXPERIMENTAL
Intervention: Implantable pulmonary artery pressure monitoring device (treatment group)
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Implantable pulmonary artery pressure monitoring device (treatment group) in COPD subgroup
Number of subjects: 550

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 550
Study: 22865831

Group type: EXPERIMENTAL
Intervention: Motor-cognition group
Number of subjects: 16

Group type: COMPARATOR
Intervention: Motor group
Number of subjects: 16
Study: 21991791

Group type: EXPERIMENTAL
Intervention: Education with printed material
Number of subjects: 364
Study: 19050164

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg daily for 28 days
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 16700869

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 15751411

Group type: EXPERIMENTAL
Intervention: MEOPA (nitrogen monoxide-oxygen mixture)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (intrarectal xylocaine instillation)
Number of subjects: 100
Study: 11343480

Group type: EXPERIMENTAL
Intervention: Medical antireflux therapy
Number of subjects: 160

Group type: COMPARATOR
Intervention: Surgical treatment (fundoplication)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Patients with Barrett esophagus
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Patients without Barrett esophagus
Number of subjects: 160
Study: 9702845

Group type: EXPERIMENTAL
Intervention: Eptastigmine 8 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Eptastigmine 20 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Eptastigmine 32 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Eptastigmine 40 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7584299

Group type: EXPERIMENTAL
Intervention: Recall of familiar actions after one year delay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recall of novel actions after one year delay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group performance
Number of subjects: 0
Study: 2685654

Group type: EXPERIMENTAL
Intervention: Sinemet CR 50/200 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional carbidopa/levodopa 25/250 mg
Number of subjects: 20
Study: 790125

Group type: EXPERIMENTAL
Intervention: Raubasine (90 mg daily for 1-2 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 30911920

Group type: EXPERIMENTAL
Intervention: Early closure of temporary ileostomy (8–13 days)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Late closure of temporary ileostomy (> 12 weeks)
Number of subjects: 112
Study: 30980892

Group type: EXPERIMENTAL
Intervention: Pudilan extract-containing toothpaste
Number of subjects: 120

Group type: COMPARATOR
Intervention: Pudilan toothpaste simulator (Control)
Number of subjects: 120
Study: 27801990

Group type: EXPERIMENTAL
Intervention: Eculizumab (administered for 4 weeks alongside standard IVIg treatment)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 8
Study: 25133710

Group type: EXPERIMENTAL
Intervention: High protein diet (1.8 g of protein·kg bw(‐1)·day(‐1))
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal protein diet (0.85 g of protein·kg bw(‐1)·day(‐1))
Number of subjects: 18
Study: 23925417

Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV) with two to three NRTIs
Number of subjects: 2220
Study: 20821200

Group type: EXPERIMENTAL
Intervention: MPCNL
Number of subjects: 54
Study: 19350183

Group type: EXPERIMENTAL
Intervention: 308-nm excimer laser treatment, lesions treated twice weekly for 13 weeks, starting with 50 to 100 mJ/cm2 and increasing by 50 mJ/cm2 until erythema appeared, for a maximum of 25 sessions or until 100% repigmentation.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Untreated control patches
Number of subjects: 34
Study: 17032095

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) combined with medication tapering
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (nonspecific therapy)
Number of subjects: 61
Study: 14645937

Group type: EXPERIMENTAL
Intervention: Behavioural cessation programme (four session treatment administered individually by a health educator, plus monthly brief phone calls until one year follow up)
Number of subjects: 261

Group type: COMPARATOR
Intervention: Self help materials only (control group)
Number of subjects: 261
Study: 10386471

Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg s.c. monthly + Flutamide 250 mg t.i.d. + Placebo daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Goserelin 3.6 mg s.c. monthly + Finasteride 10 mg (2 x 5 mg daily) + Placebo t.i.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Finasteride 10 mg (2 x 5 mg daily) + Flutamide 250 mg t.i.d.
Number of subjects: 0
Study: 8697708

Group type: EXPERIMENTAL
Intervention: Bed rest
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal daily activities
Number of subjects: 10
Study: 2038520

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (stationary bicycle ergometer) for 8 weeks, 3 sessions per week (35-40 minutes each)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no aerobic exercise)
Number of subjects: 14
Study: 6784140

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline and Diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31839082

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 7.5 mg plus fentanyl 20 μg (Group F)
Number of subjects: 65

Group type: COMPARATOR
Intervention: 0.5% bupivacaine 10 mg (Group B)
Number of subjects: 65
Study: 27849380

Group type: EXPERIMENTAL
Intervention: saxagliptin 5 mg/day plus dapagliflozin 10 mg/day
Number of subjects: 534

Group type: COMPARATOR
Intervention: saxagliptin 5 mg/day plus placebo
Number of subjects: 534

Group type: COMPARATOR
Intervention: dapagliflozin 10 mg/day plus placebo
Number of subjects: 534
Study: 26343594

Group type: EXPERIMENTAL
Intervention: Risperidone + Dextromethorphan (60 mg/day)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Risperidone + Placebo
Number of subjects: 149
Study: 25099079

Group type: EXPERIMENTAL
Intervention: Erythropoietin (40,000 IU, 8 weekly infusions)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Saline (sodium chloride [NaCl], 0.9%)
Number of subjects: 43
Study: 23173755

Group type: EXPERIMENTAL
Intervention: Levobupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 40
Study: 20810740

Group type: EXPERIMENTAL
Intervention: Audiovisual stimulation training (20 sessions, each lasting 30 minutes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Visual stimulation training (20 sessions, each lasting 30 minutes)
Number of subjects: 20
Study: 18278305

Group type: EXPERIMENTAL
Intervention: Chloral hydrate 75 mg/kg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chloral hydrate 50 mg/kg plus hydroxyzine 2.0 mg/kg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 16249417

Group type: COMPARATOR
Intervention: 30% fraction of inspired oxygen (FIO2)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 80% fraction of inspired oxygen (FIO2)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (both 30% and 80% FIO2)
Number of subjects: 300
Study: 12177096

Group type: EXPERIMENTAL
Intervention: Low-dose suramin (3.192 g/m²)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Intermediate-dose suramin (5.320 g/m²)
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: High-dose suramin (7.661 g/m²)
Number of subjects: 390
Study: 10094358

Group type: EXPERIMENTAL
Intervention: Continuous heparin drip
Number of subjects: 18

Group type: COMPARATOR
Intervention: No heparin
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 18
Study: 7769072

Group type: EXPERIMENTAL
Intervention: Co-culture with autologous granulosa-lutein cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without co-culture)
Number of subjects: 0
Study: 3174726

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMW heparin) - 15,000 Anti X-activated Factor Units, daily subcutaneous injection for 7 days after operation
Number of subjects: 92

Group type: COMPARATOR
Intervention: Calcium heparin - 5,000 International Units, 2 daily subcutaneous injections for 7 days after operation
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin
Number of subjects: 92

Group type: COMPARATOR
Intervention: Calcium heparin
Number of subjects: 92
Study: 31712711

Group type: EXPERIMENTAL
Intervention: Average Real Variability (ARV) measured by ambulatory BP monitoring
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Daytime systolic ARV
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nighttime diastolic ARV
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 100
Study: 31316148

Group type: EXPERIMENTAL
Intervention: SGA group on day 1
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SGA group on day 5
Number of subjects: 50

Group type: COMPARATOR
Intervention: SGA and AGA groups on days 1 and 5
Number of subjects: 50
Study: 29231319

Group type: EXPERIMENTAL
Intervention: Electroacupuncture and triple puncture technique (group A)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Routine electroacupuncture (group B)
Number of subjects: 36
Study: 25870177

Group type: EXPERIMENTAL
Intervention: Acupuncture (bilateral needling at PC6, depth 7 mm, mean time 17 min during anaesthesia) plus usual care
Number of subjects: 282

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 282
Study: 23007486

Group type: EXPERIMENTAL
Intervention: Postactivation potentiation (PAP) intervention with 3 preceding countermovement jumps (CMJs)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group without countermovement jumps (CMJs)
Number of subjects: 16
Study: 21531178

Group type: EXPERIMENTAL
Intervention: Educational program (Group 1)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Wait-list control group (Group 2)
Number of subjects: 110
Study: 18928413

Group type: EXPERIMENTAL
Intervention: Ziprasidone 80 or 160 mg/d (fixed dose) during Period 1
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Ziprasidone flexible doses (20-160 mg/d) during Period 2
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Overall tolerability of ziprasidone
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: QTcF intervals monitoring
Number of subjects: 63
Study: 21775917

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES) 6% 130/0.4 for 8 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Ringer's lactate (RL) solution without colloid
Number of subjects: 41
Study: 16150196

Group type: EXPERIMENTAL
Intervention: Shenqi mixture (SQM) combined with microwave coagulation
Number of subjects: 72

Group type: COMPARATOR
Intervention: Microwave coagulation (Control group)
Number of subjects: 72
Study: 11827089

Group type: EXPERIMENTAL
Intervention: Procedural similarity in analogical problem solving
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procedural similarity
Number of subjects: 0
Study: 9868725

Group type: EXPERIMENTAL
Intervention: Sai‐boku‐to
Number of subjects: 200

Group type: COMPARATOR
Intervention: Antianxiety drug (diazepam) with vitamin B complex
Number of subjects: 200
Study: 7979299

Group type: EXPERIMENTAL
Intervention: 400 mg of oral diethyldithiocarbamate (DTC) per m2 weekly for 12 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 3187472

Group type: EXPERIMENTAL
Intervention: Midazolam (5‐7.5 mg i.m., weight related)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydrocodonum (15 mg i.m.)
Number of subjects: 60
Study: 11212077

Group type: EXPERIMENTAL
Intervention: Varicocelectomy (surgical intervention)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Angiographic occlusion of the spermatic vein
Number of subjects: 385

Group type: COMPARATOR
Intervention: Uncontrolled studies on varicocelectomy
Number of subjects: 385
Study: 31676658

Group type: EXPERIMENTAL
Intervention: Behavioural Activation programme delivered by trained staff
Number of subjects: 666

Group type: COMPARATOR
Intervention: Internet-based training about depression recognition and management
Number of subjects: 666
Study: 29161911

Group type: EXPERIMENTAL
Intervention: Naikan therapy
Number of subjects: 92

Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 92
Study: 27189614

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Psychoeducation/support (PES)
Number of subjects: 71
Study: 25256070

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (no ramipril)
Number of subjects: 102
Study: 22305962

Group type: EXPERIMENTAL
Intervention: Tenting area
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Left atrial size
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Coaptation depth
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Annular dilatation
Number of subjects: 610
Study: 19914557

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs) on management of STS
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Seminal trials from the 1980s and 1990s
Number of subjects: 12000
Study: 18091483

Group type: EXPERIMENTAL
Intervention: Bryan artificial disc replacement
Number of subjects: 99

Group type: COMPARATOR
Intervention: Anterior cervical fusion
Number of subjects: 99
Study: 14998945

Group type: EXPERIMENTAL
Intervention: Coasting (withholding gonadotrophins)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (optimally responding women)
Number of subjects: 48
Study: 11667990

Group type: EXPERIMENTAL
Intervention: Ringer‐Lactate solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 0
Study: 9432077

Group type: EXPERIMENTAL
Intervention: Cefuroxime for 1 day
Number of subjects: 750

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 750
Study: 8209072

Group type: EXPERIMENTAL
Intervention: Salbutamol via metered dose inhaler (MDI)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Salbutamol via nebulizer
Number of subjects: 15
Study: 2733581

Group type: EXPERIMENTAL
Intervention: 12 weeks of endurance exercise training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (N = 10)
Number of subjects: 22
Study: 29956411

Group type: EXPERIMENTAL
Intervention: Conditioned pain modulation (CPM) with a painful cuff pressure at 70% of pressure-pain tolerance threshold (PTT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control session without conditioning
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conditioned pain modulation (CPM)
Number of subjects: 20
Study: 28821512

Group type: EXPERIMENTAL
Intervention: Culprit vessel only PCI with potentially subsequent staged revascularisation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate multivessel PCI
Number of subjects: 0
Study: 26303741

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Manual acupuncture
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Non-acupuncture
Number of subjects: 132

Group type: COMPARATOR
Intervention: Medicine control
Number of subjects: 132
Study: 23544680

Group type: EXPERIMENTAL
Intervention: 4 placebo‐tailored booklets
Number of subjects: 424

Group type: COMPARATOR
Intervention: 4 standard booklets
Number of subjects: 424
Study: 21214610

Group type: EXPERIMENTAL
Intervention: TZP-101 (80 μg/kg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 17368829

Group type: EXPERIMENTAL
Intervention: Positive social reactions
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Negative social reactions
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Neutral social reactions
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 93
Study: 16959410

Group type: EXPERIMENTAL
Intervention: Bromazepam 3 mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Bromazepam 6 mg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 12504052

Group type: EXPERIMENTAL
Intervention: 2.4 Gy
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 16 Gy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (2.4 Gy)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (16 Gy)
Number of subjects: 43
Study: 10371375

Group type: EXPERIMENTAL
Intervention: DD genotype
Number of subjects: 289

Group type: COMPARATOR
Intervention: II and ID genotypes
Number of subjects: 289